[Tumor necrosis factor alpha-induced expression and activity of alveolar macrophages matrix metalloproteinase-9 in

Ya-qing Li1, Zhen-xiang Zhang, Yong-jian Xu

  • 1Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Zhonghua Nei Ke Za Zhi
|April 21, 2006
PubMed
Abstract

Insights

Tumor necrosis factor-alpha (TNFalpha) significantly increases matrix metalloproteinase-9 (MMP-9) expression and activity in alveolar macrophages from COPD patients. This induction is linked to the NF-kappaB signaling pathway, suggesting a potential therapeutic target.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Immunology

Context:

  • Chronic obstructive pulmonary disease (COPD) is a major health concern characterized by chronic airway inflammation.
  • Alveolar macrophages (AMs) play a critical role in COPD pathogenesis.
  • Matrix metalloproteinase-9 (MMP-9) is implicated in tissue remodeling and inflammation in COPD.

Purpose:

  • To investigate the effect of tumor necrosis factor-alpha (TNFalpha) on MMP-9 expression and activity in AMs from COPD patients.
  • To elucidate the underlying molecular mechanisms, specifically the role of NF-kappaB signaling.

Summary:

  • AMs from COPD patients were stimulated with varying concentrations of TNFalpha.
  • MMP-9 gene expression and activity were significantly upregulated by TNFalpha in a dose-dependent manner.
  • NF-kappaB activation was observed at higher TNFalpha concentrations, suggesting its involvement in the pathway.

Impact:

  • This study demonstrates that TNFalpha induces MMP-9 in COPD AMs, potentially contributing to disease progression.
  • The findings highlight the NF-kappaB pathway as a key mediator, offering a potential target for novel COPD therapies.

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...